Sheddable Ternary Nanoparticles for Tumor Acidity-targeted SiRNA Delivery
Overview
Affiliations
Drug delivery systems for cancer therapy usually need to be sterically stabilized by a poly(ethylene glycol) (PEG) layer during blood circulation to minimize nonspecific interactions with serum components. However, PEGylation significantly reduces cellular uptake of the delivery systems after they accumulate at the tumor site, which markedly impairs the in vivo antitumor efficiency. Here, we develop a ternary small interfering RNA (siRNA) delivery system with tumor acidity-activated sheddable PEG layer to overcome the challenge. The sheddable nanoparticle is fabricated by introducing a tumor acidity-responsive PEGylated anionic polymer to the surface of positively charged polycation/siRNA complexes via electrostatic interaction. We show clear evidence that introducing the PEGylated anionic polymer to the surface of a nanoparticle markedly reduces its nonspecific interactions with protein. We further demonstrate that the nanoparticle is capable of deshielding the PEG layer at the slightly acidic tumor extracellular microenvironment to facilitate the delivery of siRNA to the tumor cells after accumulation at the tumor site. Accordingly, this promotes the RNA-interfering efficiencies and enhances the inhibition of tumor growth. Such delivery system with the ability to deshield the PEG layer at the target tissues has remarkable potential in cancer therapy.
Polymeric Nanoparticles for Drug Delivery.
Beach M, Nayanathara U, Gao Y, Zhang C, Xiong Y, Wang Y Chem Rev. 2024; 124(9):5505-5616.
PMID: 38626459 PMC: 11086401. DOI: 10.1021/acs.chemrev.3c00705.
Efficacy tumor therapeutic applications of stimuli-responsive block copolymer-based nano-assemblies.
Zhou J, Yang R, Chen Y, Chen D Heliyon. 2024; 10(7):e28166.
PMID: 38571609 PMC: 10987934. DOI: 10.1016/j.heliyon.2024.e28166.
Xu X, Ma J, Wang A, Zheng N Chem Sci. 2024; 15(5):1769-1781.
PMID: 38303932 PMC: 10829015. DOI: 10.1039/d3sc05504c.
Challenges and advances for glioma therapy based on inorganic nanoparticles.
Hu D, Xia M, Wu L, Liu H, Chen Z, Xu H Mater Today Bio. 2023; 20:100673.
PMID: 37441136 PMC: 10333687. DOI: 10.1016/j.mtbio.2023.100673.
Verkhovskii R, Ivanov A, Lengert E, Tulyakova K, Shilyagina N, Ermakov A Pharmaceutics. 2023; 15(5).
PMID: 37242807 PMC: 10222897. DOI: 10.3390/pharmaceutics15051566.